熱烈祝賀南京信帆生物成為美國藥典USP標準品特許經(jīng)銷商，歡迎大家咨詢訂購。
美國USP標準品中國供應商-南京信帆生物
美國藥典USP是美國政府對藥品質(zhì)量標準和檢定方法作出的技術規(guī)定，也是藥品生物試劑、使用、管理、檢驗的法律依據(jù)。對于在美國制造和銷售的藥物和相關產(chǎn)品而言，USP是*由美國食品藥品監(jiān)督管理局 (FDA)強制執(zhí)行的法定標準。此外，對于制藥和質(zhì)量控制所必需的規(guī)范，例如測試、程序和合格標準，USP-NF還可以作為明確的逐步操作指導。
美國USP標準品中國供應商-南京信帆生物
USP美國藥典正文藥品名錄分別按法定藥名字母順序排列，各藥品條目大都列有藥名、結(jié)構式、分子式、CAS登記號、成分和含量說明、包裝和貯藏規(guī)格、鑒定方法、干燥失重、熾灼殘渣、檢測方法等常規(guī)項目，正文之后還有對各種藥品進行測試的方法和要求的通用章節(jié)及對各種藥物的一般要求的通則。隨貨可提供資料---USP產(chǎn)品證書（USP Certificate）；化學品安全說明書(MSDS )
美國USP標準品中國供應商-南京信帆生物
USP標準品相關產(chǎn)品：
| Aniline (250 mg) | F036F0 |
| 3-Anilino-2-(3,4,5-trimethoxybenzyl) acrylonitrile (25 mg) (AS) | G2D383 |
| p-Anisaldehyde (3 x 500 mg) | F0M439 |
| o-Anisaldehyde (3 x 0.5 mL) | F0L524 |
| Anisole (1.2 mL/ampule; 3 ampules) | F0E216 |
| Anisyl Butyrate (5 x 0.5 mL) | F0L343 |
| Anisyl Propionate (5 x 0.5 mL) | F0L289 |
| Anisyl Phenylacetate (5 x 0.5 mL) | F0L482 |
| Antazoline Phosphate (200 mg) | R019L0 |
| Antazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[benzyl(phenyl)amino]acetamide) | F01990 |
| Anthralin (200 mg) | I0B221 |
| Allyl Anthranilate (0.5 mL/ampule; 5 ampules) | F0L016 |
| Antipyrine (200 mg) | R02990 |
| Antipyrine Related Compound A (25 mg) (3-methyl-1-phenyl-1H-pyrazol-5(4H)-one) | F0L242 |
| Antithrombin III Human (4.38 IU) | F033S0 |
| Apigenin (30 mg) (5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone) | R072R0 |
| Apigenin-7-glucoside (30 mg) | R03170 |
| Apocarotenal (3 x 50 mg) (Beta-Apo-8'-Carotenal) | F0K231 |
| Apomorphine Hydrochloride (250 mg) | I0M162 |
| Apraclonidine Hydrochloride (100 mg) | I0G001 |
| Aprepitant (150 mg) | R047A0 |
| Aprepitant Related Compound A (10 mg) (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) | F0K082 |
| Aprepitant Related Compound B (10 mg) (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) | F0K083 |
| Desfluoro Aprepitant (15 mg) (5--3-phenylmorpholino]methyl}-2H-1,2,4-triazol-3(4H)-one) | F01950 |
| Arabinose (50 mg) | F02410 |
| L-Arabinitol (250 mg) | R05730 |
| Arachidyl Alcohol (125 mg) | F001A0 |
| Argatroban (350 mg) | R057G0 |
| Argatroban Related Compound A (15 mg) ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) | F0M521 |
| Argatroban Related Compound B (20 mg) (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride) | F0M536 |
| Argatroban Related Compound C (20 mg) ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) | F0M483 |
| L-Arginine (200 mg) | I1J237 |
| Arginine Ethyl Ester Dihydrochloride (250 mg) | F0K087 |
| Arginine Hydrochloride (125 mg) | R071L0 |
| Aripiprazole (200 mg) | R045S0 |
| Aripiprazole Related Compound B (25 mg) (7-(4-hydroxy-butoxy)-3,4-dihydroquinolin-2(1H)-one) | F0L066 |
| Aripiprazole Related Compound C (25 mg) (1-(2,3-dichlorophenyl)piperazine hydrochloride) | F0L067 |
| Aripiprazole Related Compound F (25 mg) (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide) | R035L0 |
| Aripiprazole Related Compound G (25 mg) (7-quinolin-2(1H)-one) | R056Q0 |
| Arsanilic Acid (25 mg) | F |
| Aripiprazole Related Compound H (25 mg) (7-(4-butoxy)-3,4-dihydroquinolin-2(1H)-one) | F0L070 |
| Artemisinin (50 mg) ((3R,S,6R,8aS,9R,12S,12aR)-Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one) | R057Y0 |
| Artemether (100 mg) | H0M313 |
| Artemether Related Compound B (15 mg) ((3R,S,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin) | F0I295 |
| Artesunate (200 mg) | R07680 |
| Articaine (40 mg) | F0I197 |
| Articaine Hydrochloride (125 mg) | F1K153 |
| Articaine Related Compound A (40 mg) (Methyl 4-methyl-3-[2-(propylamino)acetamido]thiophene-2-carboxylate) | F0I199 |
| Articaine Related Compound B (25 mg) (4-methyl-3-thiophene-2-carboxylic acid) | F0K104 |
| Articaine Related Compound E (40 mg) (Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate) | F0I200 |
| Ascorbic Acid (1 g) (Vitamin C) | R1K253 |
| Ascorbyl Palmitate (500 mg) | R051G0 |
| Ascorbyl Stearate (500 mg) | F053E0 |
| Powdered Ashwagandha Root Extract (1 g) | F1I273 |
| Asiaticoside (30 mg) | R04440 |
| Asparagine Anhydrous (200 mg) | R05130 |
| Asparagine Monohydrate (200 mg) | F0E012 |
| Aspartame (200 mg) | R054U0 |
| Aspartame Related Compound A (25 mg) ([(2S,5S)-5-Benzyl-3,6-dioxopiperazin-2-yl]acetic acid) | R06830 |
| Aspartame Acesulfame (200 mg) | F0C137 |
| Aspartic Acid (100 mg) | R05750 |
| Aspirin (500 mg) | R059R0 |
| Astragaloside IV (100 mg) ((3beta,6alpha,9beta,16beta,20R,24S)-16,25-Dihydroxy-3-(beta-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside) | F01460 |
| Astragalus Root Dry Extract (1 g) | F01440 |
| Astaxanthin (Synthetic) (3 x 30 mg) | R036P0 |
上一篇 : 血小板衍生生長因子介紹
在線咨詢